• Healthcare providers (HCPs) who are licensed, certified or registered in Nevada;
• Pharmacies and employees thereof; operators and employees of medical facilities, and
• Persons licensed or certified under the provisions of title 57 of NRS.

A list of HCPs to who have been provided by a pharmaceutical sales representative:

• Any type of compensation with a value that exceeds $10 or Total compensation with a value that exceeds $100 in aggregate
• The name and manufacturer of each prescription drug for which the pharmaceutical sales representative provided a free sample to an HCP
• The name of each person who was given a free sample

Data points to be disclosed:

• Manufacturer name
• Representative State ID
• Transaction Date
• Recipient First, Middle and Last Name
• Recipient Professional Designation (a list of applicable designations are provided)
• NPI
• Zip Code of Practice
• Compensation Amount
• Compensation Type

If a sample drug was provided, the following fields are also required:

• Drug Name
• NDC

Pharmaceutical Manufacturer means a person who:

•   Derives, produces, prepares, compounds, mixes, cultivates, grows or processes any drug or medicine;
•   Repackages any drug or medicine for the purposes of resale; or
•   Produces or makes any devices or appliances that are restricted by federal law to sale by or on the order of a physician.

Pharmaceutical sales representative means a person who markets prescription drugs to providers of health care licensed, certified or registered in this State, pharmacies or employees thereof, operators or employees of medical facilities or persons licensed or certified under the provisions of title 57 of NRS.

Note: Reporting for Pharmaceutical Representatives, is both the individual’s responsibility as well as the manufacturer’s.

• A pharmaceutical manufacturer has to report information of all representatives and each representative’s HCP interactions but no medical device representative information is required to be submitted.
• Only manufacturers that produce drugs found on the current “List of Essential Drugs for Treating Diabetes” are required to report/notify the Department as outlined in SB539 Sec. 3.8 and 4.

• Submit the template file as an attachment via email to: [email protected]

http://dhhs.nv.gov/HCPWD/Drug_Transparency_Reporting/Pharmaceutical_Sales_Representatives/

http://dhhs.nv.gov/HCPWD/Drug_Transparency___Essential_Lists,_Reports___Resources/